161 related articles for article (PubMed ID: 25749387)
21. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.
Jacinto E; Facchinetti V; Liu D; Soto N; Wei S; Jung SY; Huang Q; Qin J; Su B
Cell; 2006 Oct; 127(1):125-37. PubMed ID: 16962653
[TBL] [Abstract][Full Text] [Related]
22. MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113.
Xu JY; Yang LL; Ma C; Huang YL; Zhu GX; Chen QL
Asian Pac J Trop Med; 2013 Sep; 6(9):743-7. PubMed ID: 23827155
[TBL] [Abstract][Full Text] [Related]
23. Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury.
Li J; Xu Z; Jiang L; Mao J; Zeng Z; Fang L; He W; Yuan W; Yang J; Dai C
Kidney Int; 2014 Jul; 86(1):86-102. PubMed ID: 24451322
[TBL] [Abstract][Full Text] [Related]
24. Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway.
Tan SH; Shui G; Zhou J; Shi Y; Huang J; Xia D; Wenk MR; Shen HM
Autophagy; 2014 Feb; 10(2):226-42. PubMed ID: 24296537
[TBL] [Abstract][Full Text] [Related]
25. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
[TBL] [Abstract][Full Text] [Related]
26. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
27. Coupling between Nutrient Availability and Thyroid Hormone Activation.
Lartey LJ; Werneck-de-Castro JP; O-Sullivan I; Unterman TG; Bianco AC
J Biol Chem; 2015 Dec; 290(51):30551-61. PubMed ID: 26499800
[TBL] [Abstract][Full Text] [Related]
28. Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.
Zhuang G; Yu K; Jiang Z; Chung A; Yao J; Ha C; Toy K; Soriano R; Haley B; Blackwood E; Sampath D; Bais C; Lill JR; Ferrara N
Sci Signal; 2013 Apr; 6(271):ra25. PubMed ID: 23592840
[TBL] [Abstract][Full Text] [Related]
29. CYP3A5 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Regulating mTORC2/Akt Signaling.
Jiang F; Chen L; Yang YC; Wang XM; Wang RY; Li L; Wen W; Chang YX; Chen CY; Tang J; Liu GM; Huang WT; Xu L; Wang HY
Cancer Res; 2015 Apr; 75(7):1470-81. PubMed ID: 25649767
[TBL] [Abstract][Full Text] [Related]
30. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.
Zhang C; Wendel AA; Keogh MR; Harris TE; Chen J; Coleman RA
Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1667-72. PubMed ID: 22307628
[TBL] [Abstract][Full Text] [Related]
31. Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.
Hua C; Guo H; Bu J; Zhou M; Cheng H; He F; Wang J; Wang X; Zhang Y; Wang Q; Zhou J; Cheng T; Xu M; Yuan W
Exp Hematol; 2014 Dec; 42(12):1031-40.e1-4. PubMed ID: 25201756
[TBL] [Abstract][Full Text] [Related]
32. Rictor in perivascular adipose tissue controls vascular function by regulating inflammatory molecule expression.
Bhattacharya I; Drägert K; Albert V; Contassot E; Damjanovic M; Hagiwara A; Zimmerli L; Humar R; Hall MN; Battegay EJ; Haas E
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2105-11. PubMed ID: 23868942
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
34. Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.
Zhang L; Tschumi BO; Lopez-Mejia IC; Oberle SG; Meyer M; Samson G; Rüegg MA; Hall MN; Fajas L; Zehn D; Mach JP; Donda A; Romero P
Cell Rep; 2016 Feb; 14(5):1206-1217. PubMed ID: 26804903
[TBL] [Abstract][Full Text] [Related]
35. Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.
Carr TD; Feehan RP; Hall MN; Rüegg MA; Shantz LM
Carcinogenesis; 2015 Apr; 36(4):487-97. PubMed ID: 25740823
[TBL] [Abstract][Full Text] [Related]
36. Tetraspanin 8-rictor-integrin α3 complex is required for glioma cell migration.
Pan SJ; Zhan SK; Pan YX; Liu W; Bian LG; Sun B; Sun QF
Int J Mol Sci; 2015 Mar; 16(3):5363-74. PubMed ID: 25761241
[TBL] [Abstract][Full Text] [Related]
37. mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression.
Sticz T; Molnár A; Márk Á; Hajdu M; Nagy N; Végső G; Micsik T; Kopper L; Sebestyén A
J Clin Pathol; 2017 May; 70(5):410-416. PubMed ID: 27729429
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
39. mTORC2 promotes cell survival through c-Myc-dependent up-regulation of E2F1.
Zou Z; Chen J; Liu A; Zhou X; Song Q; Jia C; Chen Z; Lin J; Yang C; Li M; Jiang Y; Bai X
J Cell Biol; 2015 Oct; 211(1):105-22. PubMed ID: 26459601
[TBL] [Abstract][Full Text] [Related]
40. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
